APG Asset Management
NKTR icon

APG Asset Management’s Nektar Therapeutics NKTR Stock Holding History

APG Asset Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,627
Closed -$1.05M – 977
2019
Q4 		$1.05M Sell
3,627
-7,637
-68% -$2.21M ﹤0.01% 867
2019
Q3 		$2.82M Buy
11,264
+7,711
+217% +$2.83M ﹤0.01% 786
2019
Q2 		$1.67M Hold
3,553
– – ﹤0.01% 761
2019
Q1 		$1.59M Hold
3,553
– – ﹤0.01% 782
2018
Q4 		$1.53M Buy
3,553
+600
+20% +$362K ﹤0.01% 732
2018
Q3 		$2.33M Hold
2,953
– – ﹤0.01% 719
2018
Q2 		$1.85M Buy
+2,953
New +$3.41M ﹤0.01% 726

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

APG Asset Management's NKTR Position: Q1 2020 in Review

APG Asset Management sold out of Nektar Therapeutics (NKTR) in Q1 2020, closing a stake of 3,627 shares — an estimated $1.05M sold.

APG Asset Management first reported a position in NKTR in Q2 2018 and held it in 7 quarters. The position peaked at $2.82M in Q3 2019. 245 funds tracked by Wall St. Rank hold NKTR as of Q1 2020.

  • APG Asset Management reported no remaining Nektar Therapeutics position as of Q1 2020 after selling out during the quarter.
  • APG Asset Management sold 3,627 Nektar Therapeutics shares in Q1 2020, an estimated $1.05M.
  • APG Asset Management first reported a position in Nektar Therapeutics in Q2 2018 and held it in 7 quarters.
  • APG Asset Management's Nektar Therapeutics position peaked at $2.82M in Q3 2019.
  • 245 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2020.

Based on APG Asset Management's 13F filing for Q1 2020, filed 14 May 2020.